within Pharmacolibrary.Drugs.ATC.H;

model H02AB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.81,
    Cl             = 7.55 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,
    adminCount     = 1,
    Vd             = 0.08259999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Dexamethasone is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressant properties. It is used in the treatment of a variety of conditions, including autoimmune disorders, allergies, certain cancers, cerebral edema, and is commonly employed in the management of severe COVID-19 and as adjunctive therapy in chemotherapy-induced nausea. Dexamethasone is an approved drug and remains in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after a single 4 mg oral dose of dexamethasone.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544010-00003&quot;>10.2165/00003088-200544010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15634032/&quot;>https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Spoorenberg, SM, et al., &amp; van de Garde, EM (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. <i>British journal of clinical pharmacology</i> 78(1) 78–83. DOI:<a href=&quot;https://doi.org/10.1111/bcp.12295&quot;>10.1111/bcp.12295</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24400953/&quot;>https://pubmed.ncbi.nlm.nih.gov/24400953</a></p></li><li><p>Jobe, AH, et al., &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=&quot;https://doi.org/10.1111/cts.12724&quot;>10.1111/cts.12724</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31808984/&quot;>https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end H02AB02;
